Mycophenolate Mofetil and Rapamycin Induce Apoptosis in the Human Monocytic U937 Cell Line Through Two Different Pathways

Transplant vasculopathy may be considered as an accelerated form of atherosclerosis resulting in chronic rejection of vascularized allografts. After organ transplantation, a diffuse intimal thickening is observed, leading to the development of an atherosclerosis plaque due to a significant monocyte infiltration. This results from a chronic inflammatory process induced by the immune response. In this study, we investigated the impact of two immunosuppressive drugs used in therapy initiated after organ transplantation, mycophenolate mofetil, and rapamycin, on the apoptotic response of monocytes induced or not by oxidized LDL. Here we show the pro‐apoptotic effect of these two drugs through two distinct signaling pathways and we highlight a synergistic effect of rapamycin on apoptosis induced by oxidized LDL. In conclusion, since immunosuppressive therapy using mycophenolate mofetil or rapamycin can increase the cell death in a monocyte cell line, this treatment could exert similar effects on human monocytes in transplant patients, and thus, prevent transplant vasculopathy, atherosclerosis development, and chronic allograft rejection. J. Cell. Biochem. 118: 3480–3487, 2017. © 2017 Wiley Periodicals, Inc.

[1]  J. Paul,et al.  Eicosapentaenoic acid membrane incorporation impairs ABCA1-dependent cholesterol efflux via a protein kinase A signaling pathway in primary human macrophages. , 2016, Biochimica et biophysica acta.

[2]  M. Savitskaya,et al.  Mechanisms of apoptosis , 2015, Biochemistry (Moscow).

[3]  E. Giovannetti,et al.  Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR , 2015, Oncotarget.

[4]  Jian-ying Li,et al.  Rapamycin, an mTOR inhibitor, induced apoptosis via independent mitochondrial and death receptor pathway in retinoblastoma Y79 cell. , 2015, International journal of clinical and experimental medicine.

[5]  B. Xu,et al.  Effect of inhibiting the signal of mammalian target of rapamycin on memory T cells. , 2014, Transplantation proceedings.

[6]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[7]  A. Djalilian,et al.  Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy. , 2013, Investigative Ophthalmology and Visual Science.

[8]  Bao-feng Wang,et al.  Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy , 2012, International journal of molecular sciences.

[9]  B. Lacour,et al.  Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes. , 2008, Atherosclerosis.

[10]  A. Shevchenko,et al.  Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.

[11]  Y. Castier,et al.  IAP Survivin Regulates Atherosclerotic Macrophage Survival , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[12]  C. Ferran,et al.  The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells. , 2006, Transplantation proceedings.

[13]  E. Bonifacio,et al.  Rapamycin Induces a Caspase‐Independent Cell Death in Human Monocytes , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  S. Isobe,et al.  Apoptosis, necrosis and cell proliferation-inhibition by cyclosporine A in U937 cells (a human monocytic cell line). , 2006, Pharmacological research.

[15]  I. Tabas.  Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Allison,et al.  Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. , 2005, Transplantation.

[17]  C. Ronco,et al.  Effect of cyclosporine, mycophenolate mofetil, and their combination with steroids on apoptosis in a human cultured monocytic U937 cell line. , 2005, Transplantation proceedings.

[18]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[19]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[20]  J. D. de Fijter,et al.  Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. , 2001, Blood.

[21]  G. Rieder,et al.  Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens. , 2000, Journal of cardiovascular pharmacology.

[22]  J C Reed,et al.  Mechanisms of apoptosis. , 2000, The American journal of pathology.

[23]  B. Kasiske,et al.  Explained and unexplained ischemic heart disease risk after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[24]  A. Tedgui,et al.  Apoptosis in the vasculature: mechanisms and functional importance , 2000, British journal of pharmacology.

[25]  M. Wilhelm,et al.  Transplant Vasculopathy: a Model for Coronary Artery Disease? , 2000, Herz.

[26]  J. Caulfield,et al.  Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. , 1999, Transplantation.

[27]  B. Björkerud,et al.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.

[28]  N. Persson,et al.  ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIA , 1995, Transplantation.

[29]  C. Ewel,et al.  Chronic Graft Rejection: Accelerated Transplant Arteriosclerosis , 1993, Immunological reviews.

[30]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[31]  F. McKeon.  When worlds collide: Immunosuppressants meet protein phosphatases , 1991, Cell.

[32]  F. Wollheim.  From Scandinavia , 1991 .

[33]  J. Goldstein,et al.  Scavenging for receptors , 1990, Nature.

[34]  D. Steinberg,et al.  Lipoproteins and the pathogenesis of atherosclerosis. , 1987, Circulation.

[35]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[36]  B. Lacour,et al.  Impact of polyunsaturated fatty acids on oxidized low density lipoprotein-induced U937 cell apoptosis. , 2011, Journal of atherosclerosis and thrombosis.

[37]  P. Loiseau,et al.  Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI/MS, and multivariate data analysis , 2011, Analytical and Bioanalytical Chemistry.

[38]  M. Brown,et al.  Atherosclerosis. Scavenging for receptors. , 1990, Nature.